2026年6月16日 · 自动抓取 · 最新研究 · 1 分钟阅读

Targeted degradation of CBP/p300 by CBPD-409 exhibits robust anti-myeloma activity

Leukemia, Published online: 16 June 2026; doi:10.1038/s41375-026-03004-2Targeted degradation of CBP/p300 by CBPD-409 exhibits robust anti-myeloma activity

本文自动抓取自 Leukemia，原文链接：Targeted degradation of CBP/p300 by CBPD-409 exhibits robust anti-myeloma activity

原文发布日期：2026-06-16

Back to Blog

View All Posts »

Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party study

Leukemia, Published online: 15 June 2026; doi:10.1038/s41375-026-02993-4Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party s

Direct measurement of in vivo BCR::ABL1 kinase inhibition reveals stronger potency of asciminib as compared with imatinib and nilotinib

Leukemia, Published online: 11 June 2026; doi:10.1038/s41375-026-03002-4Direct measurement of in vivo BCR::ABL1 kinase inhibition reveals stronger potency of asciminib as compared with imatinib and ni

Low-normal immunoglobulin suggests monoclonal B-cell lymphocytosis and constitutional CLL susceptibility: a dual-mechanism analysis

Leukemia, Published online: 10 June 2026; doi:10.1038/s41375-026-02987-2Low-normal immunoglobulin suggests monoclonal B-cell lymphocytosis and constitutional CLL susceptibility: a dual-mechanism analy

Nodular lymphocyte-predominant Hodgkin lymphoma controversy and insights: a global NLPHL one working group summit report

Leukemia, Published online: 10 June 2026; doi:10.1038/s41375-026-02990-7Nodular lymphocyte-predominant Hodgkin lymphoma controversy and insights: a global NLPHL one working group summit report

Related Posts

Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party study

Direct measurement of in vivo BCR::ABL1 kinase inhibition reveals stronger potency of asciminib as compared with imatinib and nilotinib

Low-normal immunoglobulin suggests monoclonal B-cell lymphocytosis and constitutional CLL susceptibility: a dual-mechanism analysis

Nodular lymphocyte-predominant Hodgkin lymphoma controversy and insights: a global NLPHL one working group summit report